title: Vestibulotoxicity with systemic gentamicin in different dosing regimens: Our experience in 46 patients.
authors.affiliation: Otolaryngology, The Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
authors.forename: M I
authors.identifier: 0000-0001-7143-2108
authors.initials: MI
authors.lastname: Syed
authors.affiliation: Division of Infectious Diseases, Department of Medicine, University of Toronto & Centre for Quality Improvement and Patient Safety, University of Toronto, Toronto, ON, Canada.
authors.forename: J A
authors.initials: JA
authors.lastname: Leis
authors.affiliation: Otology/Neurotology, University Health Network, Toronto, ON, Canada.
authors.forename: O
authors.initials: O
authors.lastname: Ilan
authors.affiliation: Toronto General Research Institute, University Health Network, Toronto, ON, Canada.
authors.forename: W L
authors.initials: WL
authors.lastname: Gold
authors.affiliation: Otology/Neurotology, University Health Network, Toronto, ON, Canada.
authors.forename: D D
authors.identifier: 0000-0002-7607-4562
authors.initials: DD
authors.lastname: Pothier
authors.affiliation: Otology/Neurotology, University Health Network, Toronto, ON, Canada.
authors.forename: J A
authors.initials: JA
authors.lastname: Rutka
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015837:Vestibular Diseases / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D000900:Anti-Bacterial Agents; D005839:Gentamicins